The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a closed-end management investment company that seeks both capital appreciation and current income. The trust primarily invests in equity and equity-related securities of companies operating in the healthcare and wellness sectors. Trading on the New York Stock Exchange under the symbol GRX, the fund provides investors with exposure to growth opportunities in healthcare through its closed-end structure.
The trust’s portfolio is diversified across a broad range of healthcare sub-industries, including pharmaceuticals, biotechnology, medical devices, and healthcare services. It allocates the majority of its assets to companies that are engaged in developing, manufacturing, or distributing treatments and products designed to improve human health and well-being. Holdings span established multinational leaders as well as emerging growth companies with innovative drug pipelines, diagnostic technologies, and wellness solutions.
An actively managed strategy drives the trust’s investment process. The portfolio manager team applies a fundamental, bottom-up approach, conducting in-depth analysis of clinical development pipelines, regulatory trends, and demographic shifts. Sector and security selection decisions are based on detailed company research and valuation assessments. Portfolio allocations are periodically adjusted in response to evolving market conditions, technological advancements, and changing healthcare landscapes.
The Gabelli Healthcare & Wellness Trust is advised by Gabelli Funds, LLC, an affiliate of GAMCO Investors, Inc., headquartered in Rye, New York. The trust’s board includes independent trustees who provide oversight of fund operations and governance. By investing in GRX, shareholders gain access to a professionally managed portfolio of healthcare and wellness businesses within a closed-end fund vehicle, which may trade at a premium or discount to its net asset value.
AI Generated. May Contain Errors.
